PROMIS NEUROSCIENCES INC. - Common Shares (PMN)
CUSIP: 74346M406
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 8,977,479
- Total 13F shares
- 3,347,909
- Share change
- +543,290
- Total reported value
- $3,849,710
- Price per share
- $1.15
- Number of holders
- 13
- Value change
- +$624,784
- Number of buys
- 3
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 74346M406?
CUSIP 74346M406 identifies PMN - PROMIS NEUROSCIENCES INC. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74346M406:
Top shareholders of PMN - PROMIS NEUROSCIENCES INC. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
20%
|
1,834,042
|
$3,686,424 | — | 30 Sep 2023 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
5.9%
|
531,915
|
$1,053,351 | — | 30 Sep 2023 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
3%
|
265,958
|
$526,677 | — | 30 Sep 2023 | |
| Gail M. Farfel |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
108,384
mixed-class rows
|
$256,091 | — | 23 Aug 2023 | |
| Northeast Financial Consultants Inc |
13F
|
Company |
1.1%
|
100,000
|
$198,030 | — | 30 Sep 2023 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.44%
|
39,191
|
$77,610 | — | 30 Sep 2023 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
0.22%
|
20,008
|
$39,622 | — | 30 Sep 2023 | |
| Claret Asset Management Corp |
13F
|
Company |
0.12%
|
10,830
|
$22,000 | — | 30 Sep 2023 | |
| Gavin T. Malenfant |
3/4/5
|
Chief Operating Officer, Director |
—
mixed-class rows
|
17,820
mixed-class rows
|
$12,342 | — | 26 Oct 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
1,666
|
$3,299 | — | 30 Sep 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
713
|
$1,000 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
388
|
$780 | — | 30 Sep 2023 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
333
|
$633 | — | 30 Sep 2023 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
149
|
$391 | — | 30 Sep 2023 | |
| AllSquare Wealth Management LLC |
13F
|
Company |
0%
|
185
|
$366 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
103
|
$204 | — | 30 Sep 2023 | |
| Daniel E. Geffken |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
2,500
|
— | — | 26 Oct 2023 |
Institutional Holders of PROMIS NEUROSCIENCES INC. - Common Shares (PMN) as of Q4 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.